Main > HEPATOLOGY > USA. A. NASH>Treat.>Long>*

---

USA. A. NASH>Treat.>Long>*'s subsections
(*) Dev. Status: Phase II
>Acting FGF21 Analogue
Company
Company Web-Site
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 2
Patent>UpDate: 2018. 07.17

USA. A. NASH>Treat.>Long>*'s products
This section has no products